Ana C Dos Anjos
Overview
Explore the profile of Ana C Dos Anjos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sobreira M, Batista T, Santana R, Arcanjo G, Jorge S, Santos M, et al.
Hematol Transfus Cell Ther
. 2024 Feb;
46 Suppl 5:S158-S162.
PMID: 38307823
Introduction: The Hb Deer Lodge (β2 His>Arg; HBB:c.8A>G) is a structural hemoglobin variant described in some populations around the world, characterized by increased oxygen affinity, but does not confer clinical...
2.
Oliveira J, Arcanjo G, Domingos I, Batista J, Pereira-Martins D, Batista T, et al.
J Stroke Cerebrovasc Dis
. 2023 Nov;
33(1):107474.
PMID: 38006767
Stroke is a devastating clinical outcome that significantly contributes to the morbidity and mortality of sickle cell anemia (SCA) patients. Despite its advantages in predicting stroke risk, transcranial Doppler screening...
3.
Batista T, Santana R, Sobreira M, Arcanjo G, Domingos I, Pereira-Martins D, et al.
Br J Haematol
. 2022 Jan;
197(1):e16-e18.
PMID: 34984667
No abstract available.
4.
Batista J, Pereira-Martins D, Falcao D, Domingos I, Arcanjo G, Hatzlhofer B, et al.
Ann Hematol
. 2021 Jun;
100(8):1921-1927.
PMID: 34125262
The clinical and phenotypic heterogeneity of patients with sickle cell anemia (SCA) is influenced by environmental and genetic factors. Several genetic modifiers, such as the KLOTHO (KL) gene, have been...
5.
Batista J, Arcanjo G, Batista T, Sobreira M, Santana R, Domingos I, et al.
Ann Hematol
. 2021 Feb;
100(4):903-911.
PMID: 33523291
Hyperbilirubinemia in patients with sickle cell anemia (SCA) as a result of enhanced erythrocyte destruction, lead to cholelithiasis development in a subset of patients. Evidence suggests that hyperbilirubinemia may be...